Trending...
- INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
PHILADELPHIA, Dec. 7, 2023 /PRNewswire/ -- Berger Montague PC is currently investigating potential violations of the federal securities laws on behalf of shareholders of Eagle Pharmaceuticals, Inc. ("Eagle") (NASDAQ: EGRX).
Eagle is a pharmaceutical company focused on developing treatments for diseases of the central nervous system or metabolic critical care, as well as oncology.
On November 9, 2023, Eagle disclosed that it would not be able to timely file its quarterly report for the second quarter of 2023 because it required additional time to complete its review of potential adjustments relating to the reporting of sales of PEMFEXY.
On this news, the price of Eagle shares fell $4.16 per share, or 30%, to close at $9.54 per share on November 9, 2023.
Then, on November 29, 2023, Eagle disclosed in a filing with the U.S. Securities and Exchange Commission that Eagle's President and Chief Executive Officer, Scott Tarriff, was resigning and that the board of directors accepted the resignation "[a]fter consideration of various alternatives, including termination with or without cause."
More on The PennZone
On this news, Eagle's share price fell $2.55, or 31%, to close at $5.68 per share on November 29, 2023.
If you are an Eagle investor and would like to learn more about our investigation, please contact Berger Montague: James Maro at [email protected] or (267) 637-3176, or Andrew Abramowitz at [email protected] or (215) 875-3015 or CLICK HERE.
Whistleblowers: Anyone with non-public information regarding Eagle is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
More on The PennZone
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
James Maro, Senior Counsel
Berger Montague
(267) 637-3176
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Eagle is a pharmaceutical company focused on developing treatments for diseases of the central nervous system or metabolic critical care, as well as oncology.
On November 9, 2023, Eagle disclosed that it would not be able to timely file its quarterly report for the second quarter of 2023 because it required additional time to complete its review of potential adjustments relating to the reporting of sales of PEMFEXY.
On this news, the price of Eagle shares fell $4.16 per share, or 30%, to close at $9.54 per share on November 9, 2023.
Then, on November 29, 2023, Eagle disclosed in a filing with the U.S. Securities and Exchange Commission that Eagle's President and Chief Executive Officer, Scott Tarriff, was resigning and that the board of directors accepted the resignation "[a]fter consideration of various alternatives, including termination with or without cause."
More on The PennZone
- $18 Price Target Issued in New Research Report After $34 Million Revenue Forecast from Acquisition; $101.5 Million Net Revenue in 2025; NAS DAQ: IQST
- West Dentistry Welcomes New Oral Surgeon to Enhance Patient Care
- Germantown Fashion & Arts Festival 2025 Draws Thousands, Celebrates Creativity in Historic Philly
- The AML Shop Launches New Financial Investigations Unit, Appoints Director to Lead the Initiative
- Casting Pro Darya Balyura Named Judge for 2025 Meals 4 Monologues Virtual Showcase
On this news, Eagle's share price fell $2.55, or 31%, to close at $5.68 per share on November 29, 2023.
If you are an Eagle investor and would like to learn more about our investigation, please contact Berger Montague: James Maro at [email protected] or (267) 637-3176, or Andrew Abramowitz at [email protected] or (215) 875-3015 or CLICK HERE.
Whistleblowers: Anyone with non-public information regarding Eagle is encouraged to confidentially assist Berger Montague's investigation or take advantage of the SEC Whistleblower program. Under this program, whistleblowers who provide original information may receive rewards totaling up to thirty percent (30%) of recoveries obtained by the SEC. For more information, contact us.
More on The PennZone
- Raidium révolutionne le diagnostic de la Sclérose en Plaques en partenariat avec l'Hôpital Fondation Adolphe de Rothschild
- New Podcast "Spreading the Good BUZZ" Hosted by Josh and Heidi Case Launches July 7th with Explosive Global Reach and a Mission to Transform Lives
- The Herbal Care, Led by Markel Bababekov, Becomes a Top Dispensary in NYC's Upper East Side
- Digital Watchdog Launches New myDW Cloud Services
- Stan Fitzgerald Appointed Acting Press Secretary for Veterans for America First VFAF Georgia State Chapter
Berger Montague, with offices in Philadelphia, Minneapolis, Delaware, Washington, D.C., San Diego, San Francisco and Chicago, has been a pioneer in securities class action litigation since its founding in 1970. Berger Montague has represented individual and institutional investors for over five decades and serves as lead counsel in courts throughout the United States.
Contacts:
James Maro, Senior Counsel
Berger Montague
(267) 637-3176
[email protected]
Andrew Abramowitz, Senior Counsel
Berger Montague
(215) 875-3015
[email protected]
SOURCE Berger Montague
Filed Under: Business
0 Comments
Latest on The PennZone
- Bio-Inspired Technology-Dynamic and Adaptable for unknown real-world environments
- Berger Montague Investigates Securities Class Action Against Hims & Hers Health Inc. (NYSE: HIMS)
- Michael Reafsnyder opens solo exhibition at Scott Richards Contemporary Art in San Francisco
- Valley Sleep Therapy Expands to Prescott with New Location at Crossings Road
- $17.4 Million Total Revenue for First Half of 2025 (up 31.8% YOY) for Global Wet Trades Services Provider with High Value Bitcoin Investments
- $12.8 Million Net Revenue for 2024 for Cloud-Based Crowdsourcing Recruitment and SaaS-Enabled HR Solutions Provider: Baiya International Group Inc
- #ChipInChipAway at Hunger Taking Place on July 10th, 2025
- Hire Virtue Announces Executive Sponsorship Opportunity for Houston Hiring Blitz & Job Fair on August 6, 2025
- Inked & Maxim Model Teisha Mechetti Turns Heads—And Builds Community Impact
- Plan to Launch Silo Technologies' Cybersecurity Pilot Program for Ultimate Nationwide Deployment via Exclusive Partnership: Stock Symbol: BULT
- Robert Michael & Co. Real Estate Team Celebrates Industry Recognition and Showcases Premier Central Florida Listings
- INVESTIGATION ALERT: Berger Montague PC Investigates Aflac, Inc.'s Board Of Directors For Breach of Fiduciary Duties (NYSE: AFL)
- AI-Based Neurotoxin Countermeasure Initiative Launched to Address Emerging National Security Needs: Renovaro, Inc. (N A S D A Q: RENB)
- The Naturist World Just Shifted — NaturismRE Ignites a Global Resurgence
- $796,000 in Q2 Revenue Marks Highest Earnings to Date on 3 Trailing Quarters of Profitability in Multi-Billion Homebuilding Sector: Stock Symbol: IVDN
- Cybersecurity is THE Hot Market Sector; Revenues, Earnings & Profit matter; Only 33 Million Shares + a Huge Short Position Equal an Undervalued Stock
- Despite Global Calls for a Ban, US Child Psychiatry Pushes Electroshock for Kids
- BeyondTrucks CEO Wins Gold Stevie® Award for Best Entrepreneur in Transportation
- Franco Polished Plaster Celebrates 35 Years of Bringing Walls to Life in the UK
- Spartan & Guardians Partner with Guitar Legend Buckethead to Support Global Child Rescue Efforts